Bristol-Myers Squibb Co. (NYSE:BMY)

CAPS Rating: 4 out of 5

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

Recs

3
Player Avatar bobg304 (75.44) Submitted: 7/4/2012 11:29:38 AM : Outperform Start Price: $33.87 BMY Score: +6.61

great dividend & a long term hold.....

Report this Post 2 Replies
Member Avatar fortuitoustrade (< 20) Submitted: 8/14/2012 9:24:45 AM
Recs: 0

Also great for a short term trade as RSI, Bollinger, and MFI indicate short term oversold. Bought 1306 shares at 31.67 www.fortuitoustrade.blogspot.com

Report this Post
Member Avatar chris293 (42.32) Submitted: 8/22/2012 10:20:19 PM
Recs: 0

BMY has a good dividend and good growth for bio and drug minded health care share holders more as a long term investment for some. Yet at times there are periods for trading for quick profit for others. Hope to pick up more on the next dip.

Report this Post

Featured Broker Partners


Advertisement